← Back

Adaptate

A newly formed spin-off of GammaDelta Therapeutics in London. Adaptate is developing new treatments for cancer, both haematological and solid tumors, using novel antibodies targeting γδ T cells. Unlike GammaDelta Therapeutics whose focus is on the development of cell based therapies, Adaptate Biotherapeutics will carve out a distinct but related area of science by developing non cell based therapies using antibodies.

LocationLondon, UK
CEONatalie Mount
Partner Tim Haines
Websitewww.adaptatebiotx.com